Ozempic / Semaglutide (GLP-1) — Signal 94

Ozempic and other GLP-1 agonists (Wegovy, Mounjaro, Zepbound) are linked to severe gastroparesis, intestinal obstruction, and gallbladder injuries. Plaintiffs allege Novo Nordisk and Eli Lilly failed to warn about delayed gastric emptying despite internal knowledge dating to clinical trials. With tens of millions exposed and the MDL still in early bellwether selection, CPL remains at floor pricing.